Lisata Therapeutics
LSTA
LSTA
21 hedge funds and large institutions have $1.46M invested in Lisata Therapeutics in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
42% less capital invested
Capital invested by funds: $2.51M → $1.46M (-$1.05M)
Holders
21
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$36.4K | |
| 2 | +$20.7K | |
| 3 | +$5.14K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$2.93K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$304 |
Top Sellers
| 1 | -$55.3K | |
| 2 | -$23.6K | |
| 3 | -$3.92K | |
| 4 |
VNA
Valley National Advisers
Bethlehem,
Pennsylvania
|
-$1K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$4 |